These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24114435

  • 1. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
    Norman C, Rollene NL, Erickson D, Miles JM, Bowers CY, Veldhuis JD.
    Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
    [Abstract] [Full Text] [Related]

  • 2. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [Abstract] [Full Text] [Related]

  • 3. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [Abstract] [Full Text] [Related]

  • 4. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C, Miles J, Bowers CY, Veldhuis JD.
    Am J Physiol Regul Integr Comp Physiol; 2013 May 01; 304(9):R712-9. PubMed ID: 23485864
    [Abstract] [Full Text] [Related]

  • 5. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2010 Jan 01; 95(1):353-60. PubMed ID: 19858315
    [Abstract] [Full Text] [Related]

  • 6. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2649-59. PubMed ID: 10946861
    [Abstract] [Full Text] [Related]

  • 7. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
    Veldhuis JD, Bowers CY.
    Am J Physiol Endocrinol Metab; 2009 May 01; 296(5):E1085-92. PubMed ID: 19240251
    [Abstract] [Full Text] [Related]

  • 8. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.
    Eur J Endocrinol; 2009 Aug 01; 161(2):293-300. PubMed ID: 19458139
    [Abstract] [Full Text] [Related]

  • 9. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2003 Nov 01; 88(11):5484-9. PubMed ID: 14602794
    [Abstract] [Full Text] [Related]

  • 10. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Jun 01; 84(6):2140-50. PubMed ID: 10372723
    [Abstract] [Full Text] [Related]

  • 11. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD, Anderson SM, Patrie JT, Bowers CY.
    J Clin Endocrinol Metab; 2004 Jan 01; 89(1):121-7. PubMed ID: 14715838
    [Abstract] [Full Text] [Related]

  • 12. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb 01; 86(2):551-60. PubMed ID: 11158008
    [Abstract] [Full Text] [Related]

  • 13. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD, Norman C, Miles JM, Bowers CY.
    J Clin Endocrinol Metab; 2012 Dec 01; 97(12):4753-60. PubMed ID: 22990092
    [Abstract] [Full Text] [Related]

  • 14. Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men.
    Veldhuis JD, Keenan DM.
    Eur J Endocrinol; 2008 Nov 01; 159(5):547-54. PubMed ID: 18703567
    [Abstract] [Full Text] [Related]

  • 15. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY.
    Clin Endocrinol (Oxf); 1997 Nov 01; 47(5):599-612. PubMed ID: 9425400
    [Abstract] [Full Text] [Related]

  • 16. E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.
    Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Dec 01; 86(12):5904-11. PubMed ID: 11739462
    [Abstract] [Full Text] [Related]

  • 17. Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.
    Veldhuis JD, Erickson D, Wigham J, Weist S, Miles JM, Bowers CY.
    J Clin Endocrinol Metab; 2011 Aug 01; 96(8):2540-7. PubMed ID: 21613353
    [Abstract] [Full Text] [Related]

  • 18. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1997 Feb 01; 82(2):590-9. PubMed ID: 9024260
    [Abstract] [Full Text] [Related]

  • 19. Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
    Veldhuis JD, Keenan DM, Bowers CY.
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct 01; 293(4):R1514-21. PubMed ID: 17686882
    [Abstract] [Full Text] [Related]

  • 20. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1993 May 01; 76(5):1202-8. PubMed ID: 8496311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.